Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 3, 2018

View Archived Issues

Deleterious mutations in SQSTM1 cause early onset neurodegeneration

Cannabis-schizophrenia association goes both ways, but unequally

How cirrhosis drug fights Alzheimer's disease

HDAC inhibition can help in DNA repair syndrome

Methylation of MORC1 predicts depression risk in humans

RegenxBio announces development of new candidate RGX-181 for CLN2 form of Batten disease

Phase I trial of Adverum's ADVM-022 gene therapy for wAMD to begin in Q4

Initial single-dose data presented from phase I study of NasoShield

Darzalex receives approval in Europe as treatment of newly diagnosed multiple myeloma

FKBP5 strikes again: Gene variant affects risk of developing chronic pain after trauma

MAP17 levels predict sensitivity of lung adenocarcinoma to chemotherapy

Development of a universally effective influenza virus

Capella BioSience describes antibodies targeting LIGHT

Invictus Oncology patents CSF1R inhibitors

Nuclear receptor RORgammaT agonists synthesized at Fudan University

Praxis Precision Medicines discovers sodium channel protein type 8 subunit alpha blockers

Cavion divulges new calcium channel inhibitors

FDA issues complete response letter for dasotraline NDA for ADHD

European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura

Incyte studies INCAGN-02385 in phase I for advanced malignancies

New phase II trial investigates MT-3724 with GEMOX in NHL

AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...